Patricia D'Amore | Academic Influence

Patricia D'Amore's AcademicInfluence.com Rankings

Patricia D'Amore

Medical

#720

World Rank

#953

Historical Rank

Ophthalmology

#13

World Rank

#18

Historical Rank

medical Degrees

Patricia D'Amore

Philosophy

#4076

World Rank

#6459

Historical Rank

Logic

#2026

World Rank

#2922

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Patricia D'Amore's Degrees

Doctorate Medicine Harvard University
PhD Ophthalmology Harvard University

Why Is Patricia D'Amore Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Patricia Ann D'Amore is a professor at Harvard Medical School, where she is the Charles L. Schepens Professor of Ophthalmology, and Professor of Pathology. Early life and career D'Amore grew up in Everett, Massachusetts and graduated from Matignon High School in Cambridge. After a 1973 BA at Regis College , she received a PhD in biology at Boston University in 1977 under the direction David Shepro.

(See a Problem?)

Patricia D'Amore's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Soluble endoglin contributes to the pathogenesis of preeclampsia (2006) (1749)
Oxygen-induced retinopathy in the mouse. (1994) (1553)
Blood Vessel Formation: What Is Its Molecular Basis? (1996) (1275)
Engineering vascularized skeletal muscle tissue (2005) (1217)
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. (2004) (987)
PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate (1998) (836)
Pericytes in the microvasculature. (1996) (798)
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. (1989) (788)
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. (1994) (767)
Regulators of angiogenesis. (1991) (762)
Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 (1999) (725)
Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. (2005) (677)
Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells (1987) (639)
Vascular endothelial growth factor and its receptors. (1996) (636)
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. (1996) (626)
Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors (2008) (571)
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. (2002) (556)
Vascular development: cellular and molecular regulation (1997) (551)
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris (2009) (478)
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. (2007) (450)
Growth factors are released by mechanically wounded endothelial cells (1989) (444)
Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. (2002) (432)
VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal Neovascularization (2003) (426)
Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. (1993) (414)
Microvascular pericytes contain muscle and nonmuscle actins (1985) (409)
Development and pathology of the hyaloid, choroidal and retinal vasculature. (2004) (388)
Differential expression of VEGF isoforms in mouse during development and in the adult (2001) (386)
Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. (2003) (368)
Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. (1999) (360)
The Mouse Gene for Vascular Endothelial Growth Factor (1996) (354)
Blood vessel maturation: vascular development comes of age. (1999) (332)
Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability (1995) (326)
Mechanisms of retinal and choroidal neovascularization. (1994) (309)
Vascular endothelial growth factor localization in the adult. (2006) (283)
IGF2: epigenetic regulation and role in development and disease. (2008) (277)
Demonstration of vasoproliferative activity from mammalian retina (1980) (274)
Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. (2012) (253)
Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen (1995) (251)
Purification and characterization of heparin-binding endothelial cell growth factors. (1986) (236)
Mechanisms of angiogenesis. (1987) (234)
NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration. (2013) (229)
Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. (1999) (228)
Microvascular pericyte contractility in vitro: comparison with other cells of the vascular wall (1987) (221)
Endothelial cell mitogens derived from retina and hypothalamus: biochemical and biological similarities (1984) (211)
Arterial versus venous endothelial cells (2008) (210)
VEGF expression and receptor activation in the choroid during development and in the adult. (2006) (209)
Signal transduction in vasculogenesis and developmental angiogenesis. (2011) (197)
Culture of retinal capillary cells using selective growth media. (1983) (193)
Role of shear-stress-induced VEGF expression in endothelial cell survival (2012) (190)
Roles for VEGF in the adult. (2007) (189)
VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma (2008) (184)
Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half‐life (1989) (181)
TGF-β Is Required for Vascular Barrier Function, Endothelial Survival and Homeostasis of the Adult Microvasculature (2009) (181)
TGFβ is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells (2004) (179)
Forty-Year Journey of Angiogenesis Translational Research (2011) (178)
Tumor Escape from Endogenous, Extracellular Matrix–Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors (2008) (172)
Acidic fibroblast growth factor enhances regeneration of processes by postnatal mammalian retinal ganglion cells in culture. (1988) (170)
Control of angiogenesis by the pericyte: molecular mechanisms and significance. (1997) (168)
Growth factor effects on cells of the vascular wall: a survey. (1993) (162)
What tangled webs they weave: Rho-GTPase control of angiogenesis (2007) (161)
Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. (2002) (160)
Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. (2005) (159)
Expression and role of VEGF in the adult retinal pigment epithelium. (2011) (151)
Acidic Fibroblast Growth Factor Enhances Peripheral Nerve Regeneration in Vivo (1989) (150)
A brief history of anti-VEGF for the treatment of ocular angiogenesis. (2012) (144)
Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. (1995) (139)
Angiogenic activity from bovine retina: partial purification and characterization. (1981) (135)
Characterization of vascular development in the mouse retina. (1988) (134)
Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis. (1996) (131)
Epoxyeicosanoids promote organ and tissue regeneration (2013) (126)
Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. (2007) (125)
Transcriptional regulation of vascular endothelial growth factor in cancer. (2005) (118)
Functional and biochemical interactions of Wnts with FrzA, a secreted Wnt antagonist. (1998) (118)
Neurite outgrowth induced by an endothelial cell mitogen isolated from retina (1986) (117)
Endothelial cell-astrocyte interactions and TGF beta are required for induction of blood-neural barrier properties. (2004) (112)
Cell-cell interactions in vascular development. (2001) (112)
Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling (2006) (111)
Acidic fibroblast growth factor atimulates adrenal chromaffin cells to proliferate and to extend neurites, but is not a long term survival factor (1988) (109)
Disorders of Vascular Permeability. (2016) (107)
Nerve growth factor and fibroblast growth factor regulate neurite outgrowth and gene expression in PC12 cells via both protein kinase C- and cAMP-independent mechanisms (1990) (103)
Optic nerve injury alters basic fibroblast growth factor localization in the retina and optic tract (1994) (103)
Comparative toxicity of mitomycin C and 5-fluorouracil in vitro. (1994) (100)
Adult human saphenous vein endothelial cells: assessment of their reproductive capacity for use in endothelial seeding of vascular prostheses. (1984) (100)
Wnt signaling in the vasculature (2004) (97)
Getting Tie(2)d up in angiogenesis. (2002) (95)
Adult tissues contain chemo-attractants for vascular endothelial cells (1980) (94)
Capillary growth: a two-cell system. (1992) (93)
Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism. (2003) (93)
Genome editing abrogates angiogenesis in vivo (2017) (92)
Breast cancer cells secreted platelet‐derived growth factor‐induced motility of vascular smooth muscle cells is mediated through neuropilin‐1 (2006) (89)
TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. (2001) (88)
Arachidonic acid metabolites in bFGF-, PDGF-, and serum-stimulated vascular cell growth. (1994) (88)
Mechanisms of endothelial growth control. (1992) (86)
Influence of pericytes on capillary endothelial cell growth. (1989) (86)
Regulation of basic fibroblast growth factor (bFGF) gene and protein expression following its release from sublethally injured endothelial cells (1995) (85)
Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation. (2004) (85)
A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling. (1999) (85)
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy (1994) (84)
Cellular interactions in vascular growth and differentiation. (2001) (84)
Vascular endothelial cell growth factor-a: not just for endothelial cells anymore. (2007) (82)
Endothelial cell regulation by transforming growth factor‐beta (1991) (81)
The demonstration of angiogenic activity from ocular tissues. Preliminary report. (1980) (80)
The function of vascular endothelial growth factor (2009) (79)
Vascular endothelial growth factor is important for brown adipose tissue development and maintenance (2013) (79)
Cell specific effects of glycosaminoglycans on the attachment and proliferation of vascular wall components. (1986) (75)
Sulfated glycosaminoglycans modify growth factor‐induced neurite outgrowth in PC12 cells (1988) (69)
Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin. (1989) (68)
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). (2006) (67)
Pericyte isolation and use in endothelial/pericyte coculture models. (2008) (64)
Neuroprotective effect of chronic infusion of basic fibroblast growth factor on seizure-associated hippocampal damage (1993) (63)
The role of hypoxia in vascular injury and repair. (2008) (63)
Inhibition of VEGF or TGF-β Signaling Activates Endothelium and Increases Leukocyte Rolling (2009) (62)
Modes of FGF release in vivo and in vitro (1990) (62)
Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. (1995) (61)
Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not (2007) (61)
VEGF expression is downregulated in nitrofen-induced congenital diaphragmatic hernia. (2004) (58)
VEGFR1 signaling in retinal angiogenesis and microinflammation (2021) (57)
CADASIL mutations impair Notch3 glycosylation by Fringe. (2005) (56)
The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages. (2012) (56)
Endomucin prevents leukocyte–endothelial cell adhesion and has a critical role under resting and inflammatory conditions (2016) (56)
Revisiting the mouse model of oxygen-induced retinopathy (2016) (55)
Identification and cloning of a secreted protein related to the cysteine-rich domain of frizzled. Evidence for a role in endothelial cell growth control. (1999) (55)
Sustained-release endotoxin. A model for inducing corneal neovascularization. (1991) (53)
The Role of Shear-Induced Transforming Growth Factor-&bgr; Signaling in the Endothelium (2013) (52)
Contextual role for angiopoietins and TGFβ1 in blood vessel stabilization (2007) (52)
Comparison of the effects of mechanical stimulation on venous and arterial smooth muscle cells in vitro. (1996) (52)
Oxidized Lipoprotein Uptake Through the CD36 Receptor Activates the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells (2016) (51)
Identification of genes involved in VEGF-mediated vascular morphogenesis using embryonic stem cell-derived cystic embryoid bodies (2004) (49)
Differential effects of VEGFR-1 and VEGFR-2 inhibition on tumor metastases based on host organ environment. (2010) (49)
TGF-β signaling is required for maintenance of retinal ganglion cell differentiation and survival (2011) (49)
Density‐dependent endothelial cell production of an inhibitor of smooth muscle cell growth (1993) (48)
Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta. (1994) (48)
Vasoactive hormones and cAMP affect pericyte contraction and stress fibresin vitro (1988) (47)
Tamoxifen toxicity in cultured retinal pigment epithelial cells is mediated by concurrent regulated cell death mechanisms. (2014) (47)
Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation (2017) (46)
Functional analysis of a mutant form of the receptor tyrosine kinase Tie2 causing venous malformations (2004) (45)
Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis (2017) (44)
The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE. (2011) (43)
Won't You Be My Neighbor? Local Induction of Arteriogenesis (2002) (43)
Therapeutic antibody targeting of Notch3 signaling prevents mural cell loss in CADASIL (2017) (42)
Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling (2017) (42)
IGF 2 : Epigenetic regulation and role in development and disease (2008) (40)
From Pathobiology to the Targeting of Pericytes for the Treatment of Diabetic Retinopathy (2015) (40)
Molecular regulation of vascular endothelial growth factor expression in the retinal pigment epithelium (2012) (39)
Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24. (2007) (37)
Culture and Study of Pericytes (1990) (37)
Heparin-mediated release of fibroblast growth factor-like activity into the circulation of rabbits. (1990) (37)
Therapeutic angiogenesis for cardiovascular disease (2001) (35)
An in vitro model for cell-cell interactions (1992) (34)
Expression and role of VEGF--a in the ciliary body. (2012) (33)
Is blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy? (2008) (33)
ErbB2 overexpression in mammary cells upregulates VEGF through the core promoter. (2005) (33)
Antiangiogenesis as a strategy for antimetastasis. (1988) (32)
Use of tritiated thymidine as a marker to compare the effects of matrix proteins on adult human vascular endothelial cell attachment: implications for seeding of vascular prostheses. (1986) (31)
Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development. (2011) (31)
Elevated levels of basic fibroblast growth factor in patients with limb ischemia. (1996) (30)
Tumor Angiogenesis and Microcirculation (2001) (29)
AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro (2017) (28)
Transcriptional repression of VEGF by ZNF24: mechanistic studies and vascular consequences in vivo. (2013) (28)
Beta-chemokine TCA3 binds to and activates rat vascular smooth muscle cells. (1996) (28)
Heparin-endothelial cell interactions. (1990) (27)
Calcium flux and ornithine decarboxylase activity in cultured endothelial cells. (1978) (27)
Retinal microangiopathy in a mouse model of inducible mural cell loss. (2014) (26)
Cell-cell interactions in vessel assembly: a model for the fundamentals of vascular remodelling. (1997) (25)
The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells* (2016) (25)
Cell-Cell Interactions in Diabetic Angiopathy (1992) (24)
Do ischemic hearts stimulate endothelial cell growth? (1984) (24)
Notch signaling functions in retinal pericyte survival. (2014) (24)
Corrigendum: Soluble endoglin contributes to the pathogenesis of preeclampsia (2006) (23)
Alterations in gene expression associated with changes in the state of endothelial differentiation. (1995) (22)
Role of cell and matrix-bound VEGF isoforms in lens development. (2009) (22)
Release of bFGF, an endothelial cell survival factor, by osmotic shock. (1999) (21)
The effect of human intraocular fluid on vascular endothelial cell migration. (1981) (21)
Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation. (2016) (21)
Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy (2015) (20)
Seeding of Dacron vascular prostheses with endothelium of aortic origin. (1983) (20)
Chemical mediators of intraocular neovascularization. (1980) (20)
Effects of hyperoxia on microvascular cells in vitro (1987) (20)
Neuropilin 1 expression correlates with differentiation status of epidermal cells and cutaneous squamous cell carcinomas (2014) (20)
Regulation of soluble neuropilin 1, an endogenous angiogenesis inhibitor, in liver development and regeneration (2014) (19)
First annual Lamport award manuscript. Platelet--endothelial interaction and the maintenance of the microvasculature. (1978) (17)
Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity (2012) (17)
Expression of fibroblast growth factor by F9 teratocarcinoma cells as a function of differentiation (1989) (17)
Heparin and Growth Control of Vascular Cells a (1989) (17)
Neuropilin 1 Receptor Is Up-Regulated in Dysplastic Epithelium and Oral Squamous Cell Carcinoma. (2016) (16)
The Transcriptional Coactivator PGC-1alpha Regulates Normal and Pathological Angiogenesis in the Retina (2011) (16)
Chapter 8 Growth Control in the retinal microvasculature (1988) (16)
Tumor angiogenesis: A physiological process or genetically determined? (1996) (16)
Tales of the cryptic: unveiling more angiogenesis inhibitors. (2002) (16)
Glycocalyx regulation of vascular endothelial growth factor receptor 2 activity (2019) (16)
Development of the endothelium. (2006) (15)
Density-dependent expression of hyaluronic acid binding to vascular cells in vitro. (1991) (15)
Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy (2017) (15)
Blood biomarkers in a mouse model of CADASIL (2016) (15)
Prevention of Proliferative Vitreoretinopathy by Suppression of Phosphatidylinositol 5-Phosphate 4-Kinases (2016) (15)
Growth Factors and Angiogenesis in Wound Healing (1997) (13)
FGF and TGF-beta: actions and interactions in biological systems. (1991) (12)
ADAM10 and ADAM17 proteases mediate proinflammatory cytokine-induced and constitutive cleavage of endomucin from the endothelial surface (2020) (12)
Alterations in endothelial superoxide dismutase levels as a function of growth state in vitro. (1992) (11)
Growth factors, angiogenesis and metastasis. (1986) (11)
Coculture Assays for Endothelial Cells-Mural Cells Interactions. (2016) (11)
Vascular Endothelial Growth Factor (VEGF) is a chemoattractant for vascular Smooth Muscle Cells (SMC) (1996) (10)
Application of CRISPR-Cas9 in eye disease. (2017) (10)
Update on the Role of the Endothelial Glycocalyx in Angiogenesis and Vascular Inflammation (2021) (9)
Culture of large vessel endothelial cells on floating collagen gels promotes a phenotype characteristic of endothelium in vivo. (2004) (9)
Ornithine Decarboxylase Activity in Cultured Endothelial Cells Stimulated by Serum, Thrombin and Serotonin (1978) (9)
Cell culture models to study retinal pigment epithelium-related pathogenesis in age-related macular degeneration. (2022) (9)
Use of size-exclusion and ion-exchange high-performance liquid chromatography for the isolation of biologically active growth factors. (1983) (9)
Kissing Cousins—evidence for a common vascular cell precursor. (2000) (8)
Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival. (2010) (8)
Elements of the Endomucin Extracellular Domain Essential for VEGF-Induced VEGFR2 Activity (2020) (8)
Rapid fibroblast growth factor-induced increases in protein phosphorylation and ornithine decarboxylase activity: regulation by heparin and comparison to nerve growth factor-induced increases. (1992) (6)
Targeting of miR-33 ameliorates phenotypes linked to age-related macular degeneration. (2021) (6)
Judah Folkman's contribution to the inhibition of angiogenesis. (2008) (5)
Retinol-induced modification of the extracellular matrix of endothelial cells: Its role in growth control (1991) (5)
The location and expression of fibroblast growth factor (FGF) in F9 visceral and parietal embryonic cells after retinoic acid-induced differentiation. (1992) (5)
Angiogenic Vascular Grafts1 (1987) (4)
The Role of Shear-Induced Transforming Growth Factor-? Signaling in the EndotheliumSignificance (2014) (4)
Capillary endothelial cell migration: loss of stress fibres in response to retina-derived growth factor (1984) (4)
TGF‐Beta is required for retinal vascular barrier function, endothelial cell survival and homeostasis of the adult retina (2009) (3)
A porous poly(-caprolactone) tissue engineering scaffold for RPE Transplantation (2012) (3)
In Vitro Coculture Models to Study Vessel Formation and Function (1996) (3)
Angiogenesis : biology and pathology (2012) (3)
VEGF Is Required for Neuroretina Survival and Function (2008) (3)
THE CRISPR/CAS9-CREATED MDM2 T309G ENHANCES VITREOUS-INDUCED EXPRESSION OF MDM2 AND PROLIFERATION AND SURVIVAL OF CELLS (2016) (2)
Retinal Pigment Epithelial–Choroid Interactions (2010) (2)
Galectin-3 Enhances Vascular Endothelial Growth Factor-A Receptor 2 Activity in the Presence of Vascular Endothelial Growth Factor (2021) (2)
ANGIOGENESIS, ANGIOGENIC GROWTH FACTORS AND DEVELOPMENT FACTORS (2006) (2)
Vessel Maturation and Perivascular Cells (2008) (2)
Macrophage efferocytosis with VEGFC and lymphangiogenesis: rescuing the broken heart (2022) (2)
All vessels are not created equal. (2013) (2)
Brief Definitive Report 483 VEGF 164-mediated Inflammation Is Required for Pathological , but Not Physiological , Ischemia-induced Retinal Neovascularization (2017) (2)
In Vitro Models of Blood Vessel Assembly (1997) (1)
Cell Communication and the Control of Endothelial Cell Growth (1990) (1)
Endomucin Plays a Role in Retinal Vascular Development and in VEGF‐Induced Endothelial Cell Migration, Growth, and Morphogenesis (2015) (1)
Vasculogenesis and Angiogenesis (2014) (1)
The Role of Matrix Components in the Control of Vascularization (1987) (1)
Endothelial Cells in Close Proximity to Retinal Pigment Epithelium Causes Outer Retinal Barrier Dysfunction via a Soluble VEGF-Dependent Mechanism (2003) (1)
Solid lipid nanoparticles for the delivery of a sustained-release small molecule antioxidant for RPE protection in dry AMD (2019) (1)
Review Therapeutic angiogenesis for cardiovascular disease (2001) (1)
Chapter 4 – Cellular signaling (2008) (1)
Preferential expression of a 130,000-Da cell surface protein by vascular wall cells in vitro and in vivo. (1988) (1)
Shedding of Endomucin by Endothelial Cells under Inflammatory Conditions: Involvement of Matrix Metalloproteases (2015) (0)
Title Page / Table of Contents, Vol. 20, Supplement 1, 1990 (1990) (0)
Pericyte Expression of VEGF in Developing Retinal Vasculature (2003) (0)
Endomucin Plays a Role in Developmental Retinal Vascularization and in VEGF-Induced Endothelial Cell Migration, Growth, and Morphogenesis In Vitro (2015) (0)
The CRISPR/Cas9-created MDM2 T309G contributes to the vitreous-induced cellular responses intrinsic to proliferative vitreoretinopathy (2016) (0)
Contents of Volume 5 (2002) (2004) (0)
Not Sure If You Are an Investigative Pathologist? Yes, You Are. (2021) (0)
Organizing Section: Retina Program Number: 5960 Poster Board Number: B0760 Presentation Time: 11:30 AM–1:15 PM iTRAQ proteomic analysis of proliferative vitreoretinopathy vitreous (2017) (0)
Overexpression of Oxygen-Stable Hif-1 in the Corneal Epithelium Results in Physiologic Neovascularization of the Corneal Stroma, Independent of VEGF Isoform (2008) (0)
Pericytes and Control of Microvascular Growth and Function (1993) (0)
Stimulation of Cultured Endothelial Cell Proliferation and Metabolism by Platelets and Vasoactive Agonists (1977) (0)
Role of the VEGF Isoforms During Eye Development and in the Maintenance of the RPE-Choriocapillaris in the Adult (2007) (0)
Activation Of The NALP3 Inflammasome In Retinal Pigment Epithelial (RPE) Cells: Implications For AMD (2011) (0)
Visualization of the Choroidal Circulation. (2004) (0)
Comparison of the Biological Activities of VEGF Isoforms (2007) (0)
Expression of Id 1 Protein in Developing Retinal Vasculature (2005) (0)
Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by suppressing VEGFR2 signaling (2016) (0)
Differences in Corneal Lymphangiogenesis Between BALB/c and C57BL/6 Mice (2007) (0)
Soluble VEGF isoforms are required for the maintenance of the retinal pigment epithelium (RPE)‐choriocapillaris complex in the adult (2008) (0)
Receptor-Interacting Protein Kinases and the NLRP3 Inflammasome Mediate Tamoxifen Toxicity of the Retinal Pigment Epithelium (2013) (0)
History of the mouse model of OIR Initial clinical observations (2016) (0)
Abstract 2392: Transcriptional repression of VEGF by Znf24, a C2H2 zinc finger protein (2010) (0)
Effect of Heat on a Model of the Bruch’s Membrane Regeneration: Implications for the Prevention of Age-Related Macular Degeneration (2009) (0)
Effect of Heat Treatment on Human Retinal Pigment Epithelial (RPE) Cell Production of Elastin (2008) (0)
AD Award Number : DAMD 17-011-0387 TITLE : EGF regulation of VEGF : Role in progression of ErbB 2 overexpressing mammary tumors (0)
Formation of Tractional Retinal Folds in Mice that Express only VEGF 188 (2003) (0)
Oxidized lipoproteins induce RPE cell death through NLRP3-inflammasome activation (2015) (0)
Genome editing abrogates angiogenesis in vivo (2017) (0)
CD36-mediated uptake of oxidized LDL induces retinal pigment epithelial cell death through NLRP3 inflammasome activation (2016) (0)
Erratum (2016) (0)
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Commentary. Author's reply (2007) (0)
Tissue engineering for the treatment of age-related macular degeneration (2010) (0)
Effect of heparin on the release of fibroblast growth factors (FGFs) from myocardium (1987) (0)
Endomucin depletion inhibits pathologic retinal vascularization in vivo (2017) (0)
Endomucin regulates Vascular Endothelial Growth Factor (VEGF) induced endothelium functions through its extracellular domain (2019) (0)
Detection of Circulating Endothelial Precursor Cells by in vivo Flow Cytometry (2005) (0)
Endomucin (EMCN) Regulates Angiogenesis by Controlling VEGFR2 Endocytosis (2018) (0)
Regulation of VEGF Expression During Retinal Pigment Epithelial Cell Differentiation (2008) (0)
Low Vision Research at the Schepens Eye Research Institute (2003) (0)
Endomucin is necessary for pathologic retinal neovascularization in vivo (2017) (0)
Notch signaling misregulation in retinal pericytes exposed to high glucose (2013) (0)
Contents of Volume 4 2002 (2004) (0)
Antagonism of PDGFRβ Inhibits Pericyte Recruitment in a Mouse Model of Corneal Neovascularization (2013) (0)
Tamoxifen Toxicity of the Retinal Pigment Epithelium is Mediated by RIP Kinase and the NLRP3 Inflammasome (2014) (0)
Recent Developments Mechanisms of Retinal and Choroidal Neovasculaiization (2005) (0)
A novel quantitative tool for the analysis of vascular phenotypes via fluorescein angiograms quantifies reduced arterial-venous vessel patterning (2016) (0)
EGF Regulation of VEGF: Role in Progression of ErbB2 Overexpressing Mammary Tumors (2004) (0)
The Effect of SEMA3F on Lymphangiogenesis in the Cornea (2008) (0)
Expression and Activation Status of VEGF Signaling Pathway During Choroidal Development and in the Adult. (2004) (0)
The Effect of Blocking Podoplanin on Lymphatic Growth in a Corneal Transplantation Model (2009) (0)
Abstract 5133: Transcriptional repression of VEGF by ZNF24: Mechanistic studies and vascular consequencesin vivo (2011) (0)
BASIC FIBROBLAST GROWTH FACTOR AND MUSCULAR DYSTROPHY. AUTHORS' REPLY (1994) (0)
Lymphangiogenesis In A Diabetic Murine Model (2006) (0)
Idelalisib inhibits neovascularization in a mouse model of oxygen-induced retinopathy (2018) (0)
An activated form of transforming growth factor 18 is produced by cocultures of endothelial cells and pericytes ( capillaries / cell-cell communication / smooth muscle cells / growth control ) (2003) (0)
Inactivation of VEGFR2 using CRISPR/Cas9 provides superior inhibition to the anti-VEGF drugs (2016) (0)
Role of Endomucin in Hypoxia-Induced Retinopathy of Prematurity (2016) (0)
The PPAR-γ Agonist Troglitazone Protects RPE Cells from Oxidized LDL Induced NLRP3-inflammasome–Mediated Cell Death (2017) (0)
7.34 Retina Reconstruction (2017) (0)
Analysis and culture of cells from patient-derived membranes in proliferative diabetic retinopathy (2015) (0)
Chloroquine-induced Retinal Toxicity In Vitro and In Vivo (2017) (0)
Elevated expression of RUNX1 by vascular endothelial cells in proliferative diabetic retinopathy (2017) (0)
Fatty Acid Binding Protein 4‐deficient Mice are Protected from Oxygen‐induced Retinal Neovascularization (2011) (0)
Tgf-β1 Is Required for Adult Retinal Vascular Barrier Function, Endothelial Cell Survival and Homeostasis (2008) (0)
Pericyte Production of VEGF is Differentiation-Dependent and Mediates Endothelial Survival (2002) (0)
Endomucin inhibits VEGF-induced endothelial cell migration, growth, and morphogenesis by modulating VEGFR2 signaling (2017) (0)
The Effect of Endomucin on Cell Surface Receptor Signaling Is Specific for Vascular Endothelial Growth Factor Receptor 2 (2022) (0)
Getting Tie(2)d up in angiogenesis The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters (2002) (0)
Inactive Cas9 blocks vitreous-induced contraction of retinal pigment epithelial cells (2018) (0)
A role for endomucin‐1 in maintaining a non‐inflammatory endothelial surface and in the regulation of leukocyte‐endothelial cell interactions (2013) (0)
Growth Control of Cultured Endothelial Cells1 (1987) (0)
Retinal pericytes in health and disease (2017) (0)
Adult Notch3 Deficient Mice Exhibit Extensive Mural Cell Loss in the Retinal Vasculature (2015) (0)
Subject Index, Vol. 20, 1990 (1990) (0)
Discovery of sterically-hindered phenol compounds with potent cytoprotective activities against ox-LDL-induced retinal pigment epithelial cell death as a potential pharmacotherapy. (2021) (0)
The Effect of 3TSR on Corneal Hem- and Lymphoangiogenesis (2007) (0)
Chloroquine toxicity of the retinal pigment epithelium and retina in vitro and a mouse model of retinal toxicity (2016) (0)
A Novel Murine Model of Orbital Inflammation (2015) (0)
Lymphatics in development and pathology: introduction to a special issue of Microvascular Research. (2014) (0)
Notch-mediated Cell-cell Interactions In The Pathophysiology Of Diabetic Retinopathy (2012) (0)
Skeletal development in vertebrates is initiated by migration of cells from cranial neural crest, somites and lateral plate (2002) (0)
The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells Please share how this access benefits you. Your story matters (2016) (0)
VEGF in the Adult (2008) (0)
Special issue: Therapeutic applications of angiogenesis and anti-angiogenesis (2007) (0)
VEGF(164) governs leukocyte dynamics and pathological neovascularization (2005) (0)
From PathobiologytotheTargetingof PericytesfortheTreatment of Diabetic Retinopathy (2015) (0)

This paper list is powered by the following services:

Other Resources About Patricia D'Amore

en.wikipedia.org

What Schools Are Affiliated With Patricia D'Amore?

Patricia D'Amore is affiliated with the following schools:

Harvard University